Athena Athena

X

Digital content for Ascentage Pharma

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ascentage Pharma
China Flag
Country
Country
China
Address
Address
218 Xinghu Street, Building B7, 7th Floor, Suzhou Industrial Park, Suzhou, Jiangsu, 215000
Telephone
Telephone
+86-512-85557777
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/aacr-2024--ascentage-pharma-to-present-three-preclinical-studies-at-2024-american-association-of-cancer-research-annual-meeting-302080735.html

PR NEWSWIRE
05 Mar 2024

https://www.prnewswire.com/news-releases/global-registrational-phase-iii-study-of-olverembatinib-hqp1351--cleared-by-fda-302061303.html

PR NEWSWIRE
13 Feb 2024

https://www.prnewswire.com/news-releases/olverembatinib-included-in-newest-guidelines-on-chronic-myeloid-leukemia-cml-management-from-the-national-comprehensive-cancer-network-nccn-302036514.html

PR NEWSWIRE
16 Jan 2024

https://www.prnewswire.com/news-releases/ascentage-pharma-presented-at-42nd-annual-jp-morgan-healthcare-conference-302032115.html

PR NEWSWIRE
10 Jan 2024

https://www.prnewswire.com/news-releases/ascentage-pharma-to-present-at-42nd-jp-morgan-healthcare-conference-302024292.html

PR NEWSWIRE
01 Jan 2024

https://www.prnewswire.com/news-releases/live-from-ash-2023--oral-report-featuring-encouraging-data-of-olverembatinib-combined-with-reduced-intensity-chemotherapy-in-patients-with-ph-all-presented-at-the-ash-annual-meeting-302016262.html

PR NEWSWIRE
14 Dec 2023

https://www.prnewswire.com/news-releases/live-from-ash-2023--results-from-chinese-studies-of-olverembatinib-presented-in-oral-report-at-the-ash-annual-meeting-for-the-sixth-consecutive-year-including-data-showing-promising-efficacy-in-patients-with-tki-resistant-andor-302013804.html

PR NEWSWIRE
13 Dec 2023

https://www.prnewswire.com/news-releases/live-from-ash-2023--ascentage-pharma-presents-the-first-dataset-of-bcl-2-inhibitor-lisaftoclax-in-patients-with-aml-demonstrating-favorable-efficacy-and-safety-302011941.html

PR NEWSWIRE
11 Dec 2023

https://www.prnewswire.com/news-releases/live-from-ash-2023--ascentage-pharma-releases-encouraging-long-term-data-of-bcl-2-inhibitor-lisaftoclax-in-rr-cll-including-an-orr-of-73-3-302010995.html

PR NEWSWIRE
11 Dec 2023

https://www.prnewswire.com/news-releases/live-from-ash-2023--ascentage-pharma-presents-updated-data-from-us-study-of-olverembatinib-further-validating-encouraging-efficacy-in-patients-resistant-to-ponatinib-or-asciminib-302011011.html

PR NEWSWIRE
11 Dec 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY